Medical/Pharmaceuticals

Huami to Host 2021 Strategy and Outlook Investor Fireside Chat with CEO Wang Huang on January 22

BEIJING, Jan. 14, 2021 /PRNewswire/ -- Huami Corp. (NYSE: HMI) today announced that it will hold a Fireside Chat conference call for investors on Friday,22 January 2021. The company will discuss its 2021 strategies for consumer and industrial health technologies, including its product plans annou...

2021-01-14 19:00 10859

ATIF Holdings Limited Announces Its IPO Client Soars 100% in the U.S. Trading Debut

LOS ANGELES, Jan. 13, 2021 /PRNewswire/ -- ATIF Holdings Limited (Nasdaq: ATIF, "ATIF"), a company providing business consulting and media services in Asia and North America, announces the client ofATIF, a China-based pharmaceutical and chemical products manufacturer, Qilian International Holding...

2021-01-13 21:00 10250

China NMPA Grants Approval for the Registrational Phase 1/2 Clinical Study for GC007g - an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL

SUZHOU and SHANGHAI, China, Jan. 13, 2021 /PRNewswire/ --  Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, has been granted approval fo...

2021-01-13 21:00 1903

GenScript Submits Application with FDA for Use of cPass™ SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening

PISCATAWAY, N.J., Jan. 13, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading research reagent provider, announced today that it has submitted an application to the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 N...

2021-01-13 20:30 5785

CES 2021 PressureDOT develops the world's smallest real-time wireless intra-abdominal pressure sensing capsule

TAIPEI, Jan. 12, 2021 /PRNewswire/ -- Hospitals and health systems across the world are looking at telehealth strategies to facilitate their advance into the telemedicine industry. PressureDOT is at the forefront of remote critical monitoring with its recently developed, world's smallest wireless...

2021-01-12 22:46 1437

IKEUCHI Launches New Fogging Device for Quick, Easy and Effective Disinfection

OSAKA, Japan, Jan. 12, 2021 /PRNewswire/ -- H. IKEUCHI & CO., LTD., a leading manufacturer of industrial and commercial spray nozzles, headquartered inJapan, has launched full-scale sales of a backpack disinfection device dubbed "Dry-Fog HIGHNOW (R)." Logo: https://kyodonewsprwire.jp/prwfile/re...

2021-01-12 16:00 1394

ClearMind Biomedical's Axonpen Neuroendoscope Receives 510K Clearance

LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- ClearMind Biomedical has received FDA clearance for its novel neuroendoscope, the Axonpen System, for illumination and visualization of intracranial tissue and fluids, and the controlled aspiration of tissue and/or fluid during surgery.

2021-01-12 01:00 1340

Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma

SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) received Compliance Program (CP) Rating of "A" from the Korea Fair Trade Commission (FTC). Yuyu Pharma (Yuyu) established its CP team in 2016 with the help of the law firm Kim & Chang. The CP tea...

2021-01-11 22:00 4796

PharmAbcine announces a research collaboration with LegoChem Biosciences

DAEJEON, South Korea, Jan. 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company has entered into a research collaboration agreement with LegoChem Bioscience...

2021-01-11 21:00 1596

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China

SHANGHAI, Jan. 9, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients inGreater China, announced today the closing of a$150 million Series B financing. The round...

2021-01-09 11:06 5903

Appian Selected by Accenture as a Core Partner in the INTIENT Network for Life Sciences

Appian brings low-code speed and automation power to help drive innovation in drug discovery and scientific research MCLEAN, Va., Jan. 9, 2021 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced that it has joined Accenture's INTIENT partner ecosystem as a core partner. The ecosystem is design...

2021-01-09 08:55 10488

Gracell Biotechnologies Announces Pricing of Initial Public Offering

SUZHOU and SHANGHAI, China, Jan. 8, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ:GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies to address major industry challenges and fulfill unmet medical ne...

2021-01-08 14:55 9929

Dr David Stamler Appointed CEO

MELBOURNE, Australia, Jan. 7, 2021 /PRNewswire/ -- The Board of Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") is pleased to announce the appointment of DrDavid Stamler to the role of Chief Executive Office effective immediately. Dr Stamler joined the Company in J...

2021-01-07 21:00 12275

CORI Innolab Launches CORI Super Recharge 96(TM): Rechargeable Super Mask on Kickstarter

SINGAPORE, Jan. 7, 2021 /PRNewswire/ -- CORI Innolab (Formerly known as CORI Traveller), the makers ofCORI SuperMask™ and SuperMask™ Active, has launched an ultra-breathable, rechargeable high-performance mask that allows users to retain the mask filtration efficacy through triboelectric mechanis...

2021-01-07 20:00 1808

VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China

SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, introducing the world's leading treatment methods and drugs into theChina market and hoping to provide more Chinese patients quick access to the world's most a...

2021-01-07 18:45 1653

Bioworkshops successfully passed EU QP audit

SUZHOU, China, Jan. 6, 2021 /PRNewswire/ -- In November 2020, Bioworkshops passed a European drug Qualified Person audit (QP audit) for manufacture of clinical drug substance and drug product at their Suzhou site. The ratification of compliance to EU GMP comes within a month of obtaining a Drug M...

2021-01-06 22:00 1891

VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding

AUSTIN, Texas, Jan. 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it has been awarded additional non-dilutive funding totaling approximately$4 million from the Walloon Region and Namur Invest,Belgium. To date, Agencies from the Walloon Region have a...

2021-01-06 21:25 9770

Seegene's COVID-19 test with saliva sample collection feature now available in Europe

SEOUL, South Korea, Jan. 6, 2021 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay...

2021-01-06 16:27 2052

Seegene's COVID-19 test with saliva sample collection feature now available in Europe

SEOUL, South Korea, Jan. 6, 2021 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay...

2021-01-06 15:45 1980

PharmAbcine to participate in BIO @ JPM and Biotech Showcase Digital during "J.P. Morgan Week 2021"

DAEJEON, South Korea, Jan. 4, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company will participate in BIO @ JPM and Biotech Showcase during the J.P. Morgan Wee...

2021-01-04 21:00 1954